Erin Duffy Selected Research

delafloxacin

1/2021	Efficacy of Delafloxacin against the Biothreat Pathogen Burkholderia pseudomallei.
3/2016	A randomized, double-blind, Phase 2 study to evaluate subjective and objective outcomes in patients with acute bacterial skin and skin structure infections treated with delafloxacin, linezolid or vancomycin.
1/2016	In Vitro Activity of Delafloxacin against Clinical Neisseria gonorrhoeae Isolates and Selection of Gonococcal Delafloxacin Resistance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Erin Duffy Research Topics

Disease

3	Gout 01/2017 - 01/2016
2	Body Weight (Weight, Body) 01/2021 - 03/2016
2	Infections 01/2021 - 03/2016
1	Melioidosis 01/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2017
1	Neoplasms (Cancer) 01/2017
1	Erythema 03/2016
1	Gonorrhea 01/2016
1	Systemic Scleroderma (Systemic Sclerosis) 01/2016
1	Pulmonary Hypertension 02/2014
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 02/2014
1	Dyspnea (Shortness of Breath) 02/2014

Drug/Important Bio-Agent (IBA)

3	delafloxacinIBA 01/2021 - 01/2016
2	ametantrone (HAQ)IBA 01/2017 - 01/2016
1	Ceftazidime (Fortum)FDA LinkGeneric 01/2021
1	Uric Acid (Urate)IBA 01/2017
1	Voriconazole (Vfend)FDA LinkGeneric 01/2017
1	Linezolid (Zyvox)FDA Link 03/2016
1	FluoroquinolonesIBA 03/2016
1	Vancomycin FDA LinkGeneric 03/2016
1	Brain Natriuretic Peptide (Natrecor)FDA Link 02/2014

Therapy/Procedure

2	Lung Transplantation 01/2017 - 01/2016
1	Ambulatory Care (Outpatient Care) 01/2017
1	Therapeutics 02/2014